Impact of Macrolide Antibiotics on Hospital Readmissions and Other Clinically Important Outcomes in Critically Ill Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Propensity Score–Matched Cohort Study-Reference-Cited by-同舟云学术

Impact of Macrolide Antibiotics on Hospital Readmissions and Other Clinically Important Outcomes in Critically Ill Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Propensity Score–Matched Cohort Study

Published:2019-03 Issue:3 Volume:39 Page:242-252
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Kiser Tyree H.¹²^ORCID,Reynolds Paul M.¹²^ORCID,Moss Marc²³,Burnham Ellen L.²³,Ho P. Michael²⁴,Vandivier Richard William²³,

Affiliation:

1. Department of Clinical Pharmacy Skaggs School of Pharmacy and Pharmaceutical Sciences University of Colorado Aurora Colorado

2. Colorado Pulmonary Outcomes Research Group (CPOR) University of Colorado Aurora Colorado

3. Division of Pulmonary Sciences and Critical Care Medicine Department of Medicine University of Colorado Aurora Colorado

4. Division of Cardiology Department of Medicine University of Colorado Aurora Colorado

Funder

Colorado Clinical and Translational Sciences Institute

National Center for Advancing Translational Sciences

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/phar.2221

Reference35 articles.

1. Morbidity & Mortality.2012 Chart Book on Cardiovascular Lung and Blood Diseases. Available fromhttps://www.nhlbi.nih.gov/files/docs/research/2012_ChartBook_508.pdf. Accessed November 16 2018.

2. GOLD.Global Initiative for Chronic Obstructive Lung Disease 2017 Report. Available fromhttp://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd/. Accessed November 15 2018.

3. Total and state‐specific medical and absenteeism costs of COPD among adults aged ≥18 years in the United States for 2010 and projections through 2020;Ford ES;Chest,2015

4. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease;Seemungal TA;Am J Respir Crit Care Med,1998

5. COPD exacerbations: defining their cause and prevention;Wedzicha JA;Lancet,2007

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Macrolide Use in Chronic Obstructive Pulmonary Disease;Progress in Inflammation Research;2024

2. Predictors of Readmission, for Patients with Chronic Obstructive Pulmonary Disease (COPD) – A Systematic Review;International Journal of Chronic Obstructive Pulmonary Disease;2023-11

3. Effect of Macrolide Antibiotics on In-Hospital Mortality Among Acute Exacerbation of COPD Patients: A Propensity Score-Matched Analysis;International Journal of Chronic Obstructive Pulmonary Disease;2022-09

4. Azithromycin Versus Beta-lactams in Hospitalized Patients with Acute Exacerbations of COPD;Journal of General Internal Medicine;2022-03-22

5. Azithromycin use prior to ICU admission is associated with a lower short-term mortality for critically ill acute exacerbations of chronic obstructive pulmonary disease patients: A retrospective cohort study;Chronic Respiratory Disease;2022-01